Simple Math:360 million doses/year * $ 3/dose = $ 1 billionIf they get say 30% bottom line, you have $ 300 million in net income.With about 150 million shares o/s, this translates into $ 2/share in eps and, a $60/share stock price.No wonder there is so much manipulation to the downside. People want cheap shares.
Bump to the Top.Simple Math
one thing i will agree on ,,is if we get approval the stock will soar well over $20 over a short period of time (0ne or two days, two weeks don't know but it won't take long)...no one can dispute that.
Agreed. The potential is there.Three ($ 3.00) per vaccine is very low, normally it is $ 10/dose.If we use $ 10/dose then HEB is a multi billion dollar operation.